Welcome
The Center for Cell Reprogramming pursues and promotes basic and translational research on in vitro and in vivo cell reprogramming. Research topics include the analysis of stem-like and progenitor cells from normal and disease tissues as well as the canonical and non-canonical roles of telomerase in senescence and growth regulation
We serve as a nidus for faculty recruitment, for internal and external research collaborations, and for facilitating funding from the National Institutes of Health, Department of Defense, pharmaceutical companies and foundations
With over 30 years of experience at GUMC Dr. Richard Schlegel has helped connect immunology and pathology research as well as pioneer technology on HPV and recently cell biology, which has resulted in what we now know as conditional reprogramming.
The Schlegel laboratory has produced some fascinating articles over the past few years. See what the latest publications are from current and past faculty and lab members!
Our laboratory is filled with unique and diverse individuals who aim for excellence in all their research. Find out who we are!
If you are a researcher and interested in submitting a request for tissue cultures or using our live cell imaging click here to go to our Forms page.
Dr. Richard Schlegel discussed his work at the latest session. Read Georgetown University Medical Center’s article on the event!
Your gift will make a tremendous difference in the progress of research in conditionally reprogrammed cells for the study of disease initiation, progression and treatment.
Schlegel Shares Updates on Preventing and Treating Cervical Cancer
May 11th, 2018
Dr. Richard Schlegel was recently invited to Georgetown’s Doctor’s Speak Out Series to discuss his work on the prevention and treatment for cervical cancer which have extended for over 30 years.…
A Bed of Mouse Cells Helps Human Cells Thrive In the Lab
January 7th, 2015
Dr. Richard Schlegel speaks with Richard Harris, NPR, to talk about using his groundbreaking techniques in cell reprogramming to test artemisinin-a drug commonly used to treat malaria-to kill cervical cancer cells.…
Medical Center Researchers Named National Academy of Inventors Fellows
December 16th, 2014
Dr. Richard Schlegel has been named one of the 2014 Fellows of the National Academy of Inventors (NAI) for his groundbreaking discovery of the HPV vaccine. Read how the technology he co-developed has helped drop HPV infections by 56 percent in the US, according to the American Cancer Society.…
Researchers Test Cancer Treatments on Patients’ Own Cells
November 13th, 2014
Dr. Richard Schlegel is quoted in The Boston Globe’s news story which highlights research recently published by Dr. Jeff Engelman, Director of Thoracic Oncology at Massachusetts General Hospital. Dr. Engelman co-led a group of physicians and researchers towards new steps in personalized cancer treament using technology invented by Dr. Schlegel.…
